Indeed, prior research from our team revealed that loss of negative regulators of noncanonical NF-κB signaling is associated with increased progression of experimental colitis and colitis-associated tumorigenesis in mice (Allen et al., 2012). The gene discussed is NFKB1; the disease is colitis.